Atlas Trials

SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate

Clinical trial NCT03944460 · COMPLETED

Trial details

NCT number
NCT03944460
Sponsor
Prof. Dr. Dieter Willbold
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer DementiaAlzheimer Disease
Start date
2018-04-09
Primary completion
2018-07-27
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.